speb/financial-data huggingface dataset:
IMPT.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 565908.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: -2.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 1519233.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1089786.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Payables: 1989760.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1989760.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 32638.00
IMPT.V income_statement (quarterly, 2025-09-30) — Pretax Income: -1497382.00
IMPT.V cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -172242.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Raw Materials: 276572.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Receivables: 234316.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -1033486.00
IMPT.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 496675.00
IMPT.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: -8574.00
IMPT.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -390931.00
IMPT.V income_statement (quarterly, 2025-09-30) — Research And Development: 650800.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -61319623.00
IMPT.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 77187.00
IMPT.V cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
IMPT.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 45908.00
IMPT.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 487510.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 17151168.00
IMPT.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 132126.00
IMPT.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 39037.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -5743425.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -6043142.00
IMPT.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IMPT.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 65056.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 10971961.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -1447586.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 14514866.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -5743425.00
IMPT.V income_statement (quarterly, 2025-09-30) — Total Expenses: 1626411.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 16715386.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 317567.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4395222.00
IMPT.V income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -1057169.00
IMPT.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 132126.00
IMPT.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 132126.00
IMPT.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -1665770.00
IMPT.V income_statement (quarterly, 2025-09-30) — Write Off: -132126.00
IMPT.V income_statement (annual, 2025-12-31) — +Operating Expense: 2765960.00
IMPT.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 532311.00
IMPT.V income_statement (annual, 2025-12-31) — +Total Revenue: 3557365.00
IMPT.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 1821859.00
IMPT.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 1915271.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1915271.00
IMPT.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 36328.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 36328.00
IMPT.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1397289.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1397289.00
IMPT.V balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2221864.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2221864.00
IMPT.V cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 426761.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 357642.00
IMPT.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 330708.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 666148.00
IMPT.V balance_sheet (annual, 2025-12-31) — Capital Stock: 53525110.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 53525110.00
IMPT.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 833338.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 833338.00
IMPT.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 833338.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 833338.00
IMPT.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
IMPT.V balance_sheet (annual, 2025-12-31) — Cash Equivalents: 833335.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 833335.00
IMPT.V balance_sheet (annual, 2025-12-31) — Cash Financial: 3.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 3.00
IMPT.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3005086.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -171389.00
IMPT.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IMPT.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2442967.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 398068.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Inventory: 1201763.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Inventory: 1480895.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 0.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 41777.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -46260.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Payable: -1234433.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Payable: -85324.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1234433.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -85324.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 44506.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 78451.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Receivables: 117532.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -172468.00
IMPT.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 171145.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1255294.00
IMPT.V cash_flow (annual, 2025-12-31) — Changes In Cash: 562119.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 226679.00
IMPT.V balance_sheet (annual, 2025-12-31) — Common Stock: 53525110.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 53525110.00
IMPT.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: -7468435.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -7468435.00
IMPT.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 3713304.00
IMPT.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2158515.00
IMPT.V balance_sheet (annual, 2025-12-31) — Current Assets: 9472819.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 9472819.00
IMPT.V balance_sheet (annual, 2025-12-31) — Current Debt: 13919839.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 13919839.00
IMPT.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 13919839.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 13919839.00
IMPT.V balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 120548.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 120548.00
IMPT.V balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 120548.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 120548.00
IMPT.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 15955658.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 15955658.00
IMPT.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: -23470.00
IMPT.V cash_flow (annual, 2025-12-31) — Deferred Tax: -23470.00
IMPT.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 86525.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7869.00
IMPT.V income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 86525.00
IMPT.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 7869.00
IMPT.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 86525.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7869.00
IMPT.V income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 86525.00
IMPT.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 7869.00
IMPT.V income_statement (annual, 2025-12-31) — Depreciation Income Statement: 86525.00
IMPT.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1714292.00
IMPT.V income_statement (annual, 2025-12-31) — EBIT: -3990651.00
IMPT.V income_statement (quarterly, 2025-12-31) — EBIT: -1868600.00
IMPT.V income_statement (annual, 2025-12-31) — EBITDA: -3904126.00
IMPT.V income_statement (quarterly, 2025-12-31) — EBITDA: -1860731.00
IMPT.V cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -59489.00
IMPT.V balance_sheet (annual, 2025-12-31) — Employee Benefits: 46356.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 46356.00
IMPT.V cash_flow (annual, 2025-12-31) — End Cash Position: 833338.00
IMPT.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 833338.00
IMPT.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3005086.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -171389.00
IMPT.V balance_sheet (annual, 2025-12-31) — Finished Goods: 8106733.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Finished Goods: 8106733.00
IMPT.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -2442967.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 398068.00
IMPT.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -45889.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -45889.00
IMPT.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 1846460.00
IMPT.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 440392.00
IMPT.V balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
IMPT.V balance_sheet (annual, 2025-12-31) — Gross PPE: 1406334.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1406334.00
IMPT.V income_statement (annual, 2025-12-31) — Gross Profit: -155939.00
IMPT.V income_statement (quarterly, 2025-12-31) — Gross Profit: -336656.00
IMPT.V income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 299717.00
IMPT.V cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
IMPT.V income_statement (annual, 2025-12-31) — Interest Expense: 1287347.00
IMPT.V income_statement (quarterly, 2025-12-31) — Interest Expense: -130838.00
IMPT.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1287347.00
IMPT.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: -130838.00
IMPT.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -307293.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -168116.00
IMPT.V balance_sheet (annual, 2025-12-31) — Inventory: 8353475.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Inventory: 8353475.00
IMPT.V balance_sheet (annual, 2025-12-31) — Invested Capital: 7399689.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 7399689.00
IMPT.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
IMPT.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 5615000.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1048000.00
IMPT.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 948285.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 948285.00
IMPT.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 948285.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 948285.00
IMPT.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 5615000.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1048000.00
IMPT.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2302621.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1051273.00
IMPT.V balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 100901.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 100901.00
IMPT.V balance_sheet (annual, 2025-12-31) — Net Debt: 14034786.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 14034786.00
IMPT.V income_statement (annual, 2025-12-31) — Net Income: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Income: -1714292.00
IMPT.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1714292.00
IMPT.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1714292.00
IMPT.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1714292.00
IMPT.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1714292.00
IMPT.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -5254528.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1714292.00
IMPT.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -5254528.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1714292.00
IMPT.V cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
IMPT.V income_statement (annual, 2025-12-31) — Net Interest Income: -1287347.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Interest Income: 130838.00
IMPT.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 3312379.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3273.00
IMPT.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 3312379.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3273.00
IMPT.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1287347.00
IMPT.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 130838.00
IMPT.V balance_sheet (annual, 2025-12-31) — Net PPE: 9045.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 9045.00
IMPT.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
IMPT.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -7468435.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -7468435.00
IMPT.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 0.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
IMPT.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
IMPT.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -2829568.00
IMPT.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -855292.00
IMPT.V income_statement (annual, 2025-12-31) — Normalized Income: -4184748.30
IMPT.V income_statement (quarterly, 2025-12-31) — Normalized Income: -708853.00
IMPT.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -2442967.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 398068.00
IMPT.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -17838.00
IMPT.V income_statement (annual, 2025-12-31) — Operating Income: -2921899.00
IMPT.V income_statement (quarterly, 2025-12-31) — Operating Income: -868967.00
IMPT.V income_statement (annual, 2025-12-31) — Operating Revenue: 3557365.00
IMPT.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 1821859.00
IMPT.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 17151168.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 17151168.00
IMPT.V balance_sheet (annual, 2025-12-31) — Other Current Assets: 24051.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 24051.00
IMPT.V balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 13919839.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 13919839.00
IMPT.V balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -45889.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -45889.00
IMPT.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: -135605.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -135605.00
IMPT.V income_statement (annual, 2025-12-31) — Other Gand A: 1466415.00
IMPT.V income_statement (quarterly, 2025-12-31) — Other Gand A: 333749.00
IMPT.V income_statement (annual, 2025-12-31) — Other Income Expense: -1068752.00
IMPT.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -999633.00
IMPT.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1935996.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 485205.00
IMPT.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 5806.00
IMPT.V balance_sheet (annual, 2025-12-31) — Other Properties: 1305433.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 1305433.00
IMPT.V balance_sheet (annual, 2025-12-31) — Other Receivables: 1299412.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1299412.00
IMPT.V balance_sheet (annual, 2025-12-31) — Payables: 1915271.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Payables: 1915271.00
IMPT.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1915271.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1915271.00
IMPT.V cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -17838.00
IMPT.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 14693.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 14693.00
IMPT.V income_statement (annual, 2025-12-31) — Pretax Income: -5277998.00
IMPT.V income_statement (quarterly, 2025-12-31) — Pretax Income: -1737762.00
IMPT.V cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 44828.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 17670.00
IMPT.V cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
IMPT.V balance_sheet (annual, 2025-12-31) — Raw Materials: 246742.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Raw Materials: 246742.00
IMPT.V balance_sheet (annual, 2025-12-31) — Receivables: 247262.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Receivables: 247262.00
IMPT.V balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -1091412.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -1091412.00
IMPT.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3713304.00
IMPT.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2158515.00
IMPT.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 86525.00
IMPT.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7869.00
IMPT.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2302621.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1051273.00
IMPT.V income_statement (annual, 2025-12-31) — Research And Development: 698400.00
IMPT.V income_statement (quarterly, 2025-12-31) — Research And Development: 47600.00
IMPT.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -63033915.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -63033915.00
IMPT.V income_statement (annual, 2025-12-31) — Salaries And Wages: 380045.00
IMPT.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 106643.00
IMPT.V cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
IMPT.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 134575.00
IMPT.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 36450.00
IMPT.V income_statement (annual, 2025-12-31) — Selling General And Administration: 1981035.00
IMPT.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 476842.00
IMPT.V balance_sheet (annual, 2025-12-31) — Share Issued: 17151168.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 17151168.00
IMPT.V income_statement (annual, 2025-12-31) — Special Income Charges: -1074558.00
IMPT.V income_statement (quarterly, 2025-12-31) — Special Income Charges: -1005439.00
IMPT.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 187614.00
IMPT.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 29988.00
IMPT.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: -7468435.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -7468435.00
IMPT.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: -7468435.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -7468435.00
IMPT.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -4778.30
IMPT.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IMPT.V income_statement (annual, 2025-12-31) — Tax Provision: -23470.00
IMPT.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IMPT.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
IMPT.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 2934.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 2934.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Assets: 9481864.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 9481864.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Capitalization: -6520150.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -6520150.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Debt: 14868124.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 14868124.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -7468435.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -7468435.00
IMPT.V income_statement (annual, 2025-12-31) — Total Expenses: 6479264.00
IMPT.V income_statement (quarterly, 2025-12-31) — Total Expenses: 2690826.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 16950299.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 16950299.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 9045.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 9045.00
IMPT.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 994641.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 994641.00
IMPT.V income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2734285.00
IMPT.V income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -838979.00
IMPT.V income_statement (annual, 2025-12-31) — Total Unusual Items: -1074558.00
IMPT.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1005439.00
IMPT.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1074558.00
IMPT.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1005439.00
IMPT.V balance_sheet (annual, 2025-12-31) — Working Capital: -6482839.00
IMPT.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -6482839.00
IMPT.V income_statement (annual, 2025-12-31) — Write Off: 774841.00
IMPT.V income_statement (quarterly, 2025-12-31) — Write Off: 705722.00
IMR.AX income_statement (annual, 2021-12-31) — Basic Average Shares: 135064873.00
IMR.AX income_statement (annual, 2021-12-31) — Basic EPS: -0.15
IMR.AX balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 1354428.00
IMR.AX balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 1354428.00
IMR.AX income_statement (annual, 2021-12-31) — Diluted Average Shares: 135064873.00
IMR.AX income_statement (annual, 2021-12-31) — Diluted EPS: -0.15
IMR.AX balance_sheet (annual, 2021-12-31) — Inventories Adjustments Allowances: -955226.00
IMR.AX cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -69560.00
IMR.AX cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -824800.00
IMR.AX balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 175286.00
IMR.AX balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 509604.00
IMR.AX cash_flow (annual, 2021-12-31) — Purchase Of Investment: -69560.00
IMR.AX income_statement (annual, 2022-12-31) — +Operating Expense: 16468301.00
IMR.AX income_statement (annual, 2022-12-31) — +Total Revenue: 816011.00
IMR.AX balance_sheet (annual, 2022-12-31) — Accounts Payable: 259267.00
IMR.AX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 125544.00
IMR.AX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2545485.00
IMR.AX income_statement (annual, 2022-12-31) — Basic Average Shares: 150495068.00
IMR.AX income_statement (annual, 2022-12-31) — Basic EPS: -0.12
IMR.AX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 18516208.00
IMR.AX cash_flow (annual, 2022-12-31) — Capital Expenditure: -238859.00
IMR.AX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2307107.00
IMR.AX balance_sheet (annual, 2022-12-31) — Capital Stock: 97471424.00
IMR.AX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 5687816.00
IMR.AX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 5687816.00
IMR.AX balance_sheet (annual, 2022-12-31) — Cash Financial: 5687816.00
IMR.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 3943432.00
IMR.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -238859.00
IMR.AX cash_flow (annual, 2022-12-31) — Cash Flowsfromusedin Operating Activities Direct: -16510221.00
IMR.AX cash_flow (annual, 2022-12-31) — Changes In Cash: -12805648.00
IMR.AX cash_flow (annual, 2022-12-31) — Classesof Cash Receiptsfrom Operating Activities: -16510221.00
IMR.AX balance_sheet (annual, 2022-12-31) — Common Stock: 97471424.00
IMR.AX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 7510440.00
IMR.AX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 4371233.00
IMR.AX cash_flow (annual, 2022-12-31) — Common Stock Payments: -70673.00
IMR.AX income_statement (annual, 2022-12-31) — Cost Of Revenue: 2342795.00
IMR.AX balance_sheet (annual, 2022-12-31) — Current Assets: 9684314.00
IMR.AX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 867177.00
IMR.AX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 867177.00
IMR.AX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 924936.00
IMR.AX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 924936.00
IMR.AX balance_sheet (annual, 2022-12-31) — Current Liabilities: 2074738.00
IMR.AX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 712491.00
IMR.AX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 712491.00
IMR.AX income_statement (annual, 2022-12-31) — Depreciation Income Statement: 712491.00
IMR.AX income_statement (annual, 2022-12-31) — Diluted Average Shares: 150495068.00
IMR.AX income_statement (annual, 2022-12-31) — Diluted EPS: -0.12
IMR.AX income_statement (annual, 2022-12-31) — EBIT: -17178350.00
IMR.AX income_statement (annual, 2022-12-31) — EBITDA: -16465859.00
IMR.AX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -22744.00
IMR.AX cash_flow (annual, 2022-12-31) — End Cash Position: 5687816.00
IMR.AX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3943432.00
IMR.AX balance_sheet (annual, 2022-12-31) — Finished Goods: 997871.00
IMR.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: -16749080.00
IMR.AX income_statement (annual, 2022-12-31) — General And Administrative Expense: 4982404.00
IMR.AX balance_sheet (annual, 2022-12-31) — Gross PPE: 6105269.00
IMR.AX income_statement (annual, 2022-12-31) — Gross Profit: -1526784.00
IMR.AX income_statement (annual, 2022-12-31) — Interest Expense: 177917.00
IMR.AX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 177917.00
IMR.AX income_statement (annual, 2022-12-31) — Interest Income: 107999.00
IMR.AX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 107999.00
IMR.AX balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -577469.00
IMR.AX balance_sheet (annual, 2022-12-31) — Inventory: 2276743.00
IMR.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 9693340.00
IMR.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -238859.00
IMR.AX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 4371233.00
IMR.AX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 839148.00
IMR.AX balance_sheet (annual, 2022-12-31) — Leases: 1641837.00
IMR.AX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1439930.00
IMR.AX balance_sheet (annual, 2022-12-31) — Long Term Debt: 2182900.00
IMR.AX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3622830.00
IMR.AX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 839148.00
IMR.AX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -864121.00
IMR.AX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3467004.00
IMR.AX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 4300560.00
IMR.AX income_statement (annual, 2022-12-31) — Net Income: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Net Interest Income: -69918.00
IMR.AX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -24973.00
IMR.AX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -24973.00
IMR.AX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -69918.00
IMR.AX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -664310.00
IMR.AX balance_sheet (annual, 2022-12-31) — Net PPE: 3559784.00
IMR.AX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -238859.00
IMR.AX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7510440.00
IMR.AX balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 228984.00
IMR.AX income_statement (annual, 2022-12-31) — Normalized EBITDA: -16465859.00
IMR.AX income_statement (annual, 2022-12-31) — Normalized Income: -17356267.00
IMR.AX income_statement (annual, 2022-12-31) — Operating Income: -17995085.00
IMR.AX income_statement (annual, 2022-12-31) — Operating Revenue: 816011.00
IMR.AX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 156280436.00
IMR.AX cash_flow (annual, 2022-12-31) — Other Cash Receiptsfrom Operating Activities: -16510221.00
IMR.AX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 23358.00
IMR.AX income_statement (annual, 2022-12-31) — Other Gand A: 4982404.00
IMR.AX income_statement (annual, 2022-12-31) — Other Income Expense: -3755.00
IMR.AX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 227779.00
IMR.AX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 492853.00
IMR.AX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -3755.00
IMR.AX income_statement (annual, 2022-12-31) — Other Operating Expenses: 22508.00
IMR.AX balance_sheet (annual, 2022-12-31) — Other Properties: 996428.00
IMR.AX balance_sheet (annual, 2022-12-31) — Payables: 259267.00
IMR.AX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 259267.00
IMR.AX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1594211.00
IMR.AX income_statement (annual, 2022-12-31) — Pretax Income: -17356267.00
IMR.AX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -238859.00
IMR.AX balance_sheet (annual, 2022-12-31) — Raw Materials: 1456282.00
IMR.AX balance_sheet (annual, 2022-12-31) — Receivables: 125544.00
IMR.AX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2342795.00
IMR.AX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 712491.00
IMR.AX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -864121.00
IMR.AX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -70673.00
IMR.AX income_statement (annual, 2022-12-31) — Research And Development: 7946129.00
IMR.AX balance_sheet (annual, 2022-12-31) — Retained Earnings: -89960984.00
IMR.AX income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 2804769.00
IMR.AX income_statement (annual, 2022-12-31) — Selling General And Administration: 7787173.00
IMR.AX balance_sheet (annual, 2022-12-31) — Share Issued: 156280436.00
IMR.AX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7510440.00
IMR.AX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 7510440.00
IMR.AX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IMR.AX income_statement (annual, 2022-12-31) — Tax Provision: 0.00
IMR.AX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Assets: 13700861.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Capitalization: 9693340.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Debt: 4490007.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7510440.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 6190421.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4016547.00
IMR.AX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4115683.00
IMR.AX balance_sheet (annual, 2022-12-31) — Work In Process: 400059.00
IMR.AX balance_sheet (annual, 2022-12-31) — Working Capital: 7609576.00
IMR.AX income_statement (annual, 2023-12-31) — +Operating Expense: 16459507.00
IMR.AX income_statement (annual, 2023-12-31) — +Total Revenue: 615568.00
IMR.AX balance_sheet (annual, 2023-12-31) — Accounts Payable: 2104144.00
IMR.AX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 392557.00
IMR.AX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3211684.00
IMR.AX income_statement (annual, 2023-12-31) — Basic Average Shares: 161715078.00
IMR.AX income_statement (annual, 2023-12-31) — Basic EPS: -0.14
IMR.AX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 5687816.00
IMR.AX cash_flow (annual, 2023-12-31) — Capital Expenditure: -82783.00
IMR.AX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1439772.00
IMR.AX balance_sheet (annual, 2023-12-31) — Capital Stock: 103833521.00
IMR.AX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 831522.00
IMR.AX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 831522.00
IMR.AX balance_sheet (annual, 2023-12-31) — Cash Financial: 831522.00
IMR.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 8213659.00
IMR.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -82783.00
IMR.AX cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: -12977456.00
IMR.AX cash_flow (annual, 2023-12-31) — Changes In Cash: -4846580.00
IMR.AX cash_flow (annual, 2023-12-31) — Classesof Cash Receiptsfrom Operating Activities: -12977456.00
IMR.AX balance_sheet (annual, 2023-12-31) — Common Stock: 103833521.00
IMR.AX balance_sheet (annual, 2023-12-31) — Common Stock Equity: -8753365.00
IMR.AX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 5847517.00
IMR.AX cash_flow (annual, 2023-12-31) — Common Stock Payments: -85266.00
IMR.AX income_statement (annual, 2023-12-31) — Cost Of Revenue: 1731407.00
IMR.AX balance_sheet (annual, 2023-12-31) — Current Assets: 3940139.00
IMR.AX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 303171.00
IMR.AX balance_sheet (annual, 2023-12-31) — Current Debt: 364751.00
IMR.AX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 667922.00
IMR.AX balance_sheet (annual, 2023-12-31) — Current Liabilities: 4568347.00
IMR.AX balance_sheet (annual, 2023-12-31) — Current Notes Payable: 364751.00
IMR.AX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 707545.00
IMR.AX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 707545.00
IMR.AX income_statement (annual, 2023-12-31) — Depreciation Income Statement: 707545.00
IMR.AX balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 1945276.00
IMR.AX income_statement (annual, 2023-12-31) — Diluted Average Shares: 161715078.00
IMR.AX income_statement (annual, 2023-12-31) — Diluted EPS: -0.14
IMR.AX income_statement (annual, 2023-12-31) — EBIT: -22577955.00
IMR.AX income_statement (annual, 2023-12-31) — EBITDA: -21870410.00
IMR.AX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -9714.00
IMR.AX cash_flow (annual, 2023-12-31) — End Cash Position: 831522.00
IMR.AX balance_sheet (annual, 2023-12-31) — Financial Assets: 56243.00
IMR.AX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 8213659.00
IMR.AX balance_sheet (annual, 2023-12-31) — Finished Goods: 1227681.00
IMR.AX cash_flow (annual, 2023-12-31) — Free Cash Flow: -13060239.00
IMR.AX income_statement (annual, 2023-12-31) — General And Administrative Expense: 5087841.00
IMR.AX balance_sheet (annual, 2023-12-31) — Gross PPE: 6377245.00
IMR.AX income_statement (annual, 2023-12-31) — Gross Profit: -1115839.00
IMR.AX income_statement (annual, 2023-12-31) — Interest Expense: 47947.00
IMR.AX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 47947.00
IMR.AX income_statement (annual, 2023-12-31) — Interest Income: 63013.00
IMR.AX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 63013.00
IMR.AX balance_sheet (annual, 2023-12-31) — Inventory: 1681354.00
IMR.AX balance_sheet (annual, 2023-12-31) — Invested Capital: 227877.00
IMR.AX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -82783.00
IMR.AX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 69560.00
IMR.AX balance_sheet (annual, 2023-12-31) — Investments And Advances: 122157.00
IMR.AX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 5847517.00
IMR.AX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3306447.00
IMR.AX balance_sheet (annual, 2023-12-31) — Leases: 1641837.00
IMR.AX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1136601.00
IMR.AX balance_sheet (annual, 2023-12-31) — Long Term Debt: 8616491.00
IMR.AX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9753092.00
IMR.AX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3306447.00
IMR.AX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -683786.00
IMR.AX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3844157.00
IMR.AX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 5762251.00
IMR.AX balance_sheet (annual, 2023-12-31) — Net Debt: 8149720.00
IMR.AX income_statement (annual, 2023-12-31) — Net Income: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Net Interest Income: 15066.00
IMR.AX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 2622661.00
IMR.AX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 2622661.00
IMR.AX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 15066.00
IMR.AX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -331933.00
IMR.AX balance_sheet (annual, 2023-12-31) — Net PPE: 3165561.00
IMR.AX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -82783.00
IMR.AX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -8753365.00
IMR.AX balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 185854.00
IMR.AX income_statement (annual, 2023-12-31) — Normalized EBITDA: -21870410.00
IMR.AX income_statement (annual, 2023-12-31) — Normalized Income: -22625902.00
IMR.AX income_statement (annual, 2023-12-31) — Operating Income: -17575346.00
IMR.AX income_statement (annual, 2023-12-31) — Operating Revenue: 615568.00
IMR.AX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 174423613.00
IMR.AX cash_flow (annual, 2023-12-31) — Other Cash Receiptsfrom Operating Activities: -12977456.00
IMR.AX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1796281.00
IMR.AX income_statement (annual, 2023-12-31) — Other Gand A: 5087841.00
IMR.AX income_statement (annual, 2023-12-31) — Other Income Expense: -5773167.00
IMR.AX balance_sheet (annual, 2023-12-31) — Other Investments: 52597.00
IMR.AX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 838365.00
IMR.AX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 794969.00
IMR.AX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -5773167.00
IMR.AX income_statement (annual, 2023-12-31) — Other Operating Expenses: 12797.00
IMR.AX balance_sheet (annual, 2023-12-31) — Other Properties: 891251.00
IMR.AX balance_sheet (annual, 2023-12-31) — Payables: 2104144.00
IMR.AX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2104144.00
IMR.AX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1034706.00
IMR.AX income_statement (annual, 2023-12-31) — Pretax Income: -22625902.00
IMR.AX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -82783.00
IMR.AX balance_sheet (annual, 2023-12-31) — Raw Materials: 98169.00
IMR.AX balance_sheet (annual, 2023-12-31) — Receivables: 392557.00
IMR.AX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1731407.00
IMR.AX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 707545.00
IMR.AX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -683786.00
IMR.AX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -85266.00
IMR.AX income_statement (annual, 2023-12-31) — Research And Development: 7919568.00
IMR.AX balance_sheet (annual, 2023-12-31) — Retained Earnings: -112586886.00
IMR.AX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 2731756.00
IMR.AX income_statement (annual, 2023-12-31) — Selling General And Administration: 7819597.00
IMR.AX balance_sheet (annual, 2023-12-31) — Share Issued: 174423613.00
IMR.AX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -8753365.00
IMR.AX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -8753365.00
IMR.AX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IMR.AX income_statement (annual, 2023-12-31) — Tax Provision: 0.00
IMR.AX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Assets: 8308319.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Capitalization: -136874.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Debt: 10421014.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -8753365.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 17061684.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 4368180.00
IMR.AX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 12493337.00
IMR.AX balance_sheet (annual, 2023-12-31) — Trading Securities: 69560.00
IMR.AX balance_sheet (annual, 2023-12-31) — Work In Process: 355504.00
IMR.AX balance_sheet (annual, 2023-12-31) — Working Capital: -628208.00
IMR.AX income_statement (annual, 2024-12-31) — +Operating Expense: 16139539.00
IMR.AX income_statement (annual, 2024-12-31) — +Total Revenue: 959424.00
IMR.AX balance_sheet (annual, 2024-12-31) — Accounts Payable: 334870.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 334870.00
IMR.AX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 345342.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 345342.00
IMR.AX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -3870159.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -3870159.00
IMR.AX income_statement (annual, 2024-12-31) — Basic Average Shares: 223999081.00
IMR.AX income_statement (annual, 2024-12-31) — Basic EPS: -0.13
IMR.AX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 831522.00
IMR.AX cash_flow (annual, 2024-12-31) — Capital Expenditure: -77976.00
IMR.AX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1134845.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1134845.00
IMR.AX balance_sheet (annual, 2024-12-31) — Capital Stock: 134902684.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 134902684.00
IMR.AX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 15707739.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 15707739.00
IMR.AX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 15707739.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 15707739.00
IMR.AX balance_sheet (annual, 2024-12-31) — Cash Financial: 15707739.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 15707739.00
IMR.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 30334214.00